- Sections
- C - Chimiemétallurgie
- C40B - Chimie combinatoirebibliothèques, p. ex. chimiothèques
- C40B 30/08 - Procédés de criblage des bibliothèques en mesurant l'activité catalytique
Détention brevets de la classe C40B 30/08
Brevets de cette classe: 74
Historique des publications depuis 10 ans
|
4
|
4
|
2
|
3
|
2
|
9
|
2
|
1
|
2
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| HTE GmbH The High Throughput Experimentation Company | 61 |
5 |
| 1859, Inc. | 16 |
5 |
| Cyclenium Pharma Inc. | 11 |
4 |
| Hypharm GmbH | 11 |
3 |
| The Regents of the University of California | 20268 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 775 |
2 |
| Massachusetts Institute of Technology | 10130 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6526 |
2 |
| National Taiwan University | 1272 |
2 |
| Ginkgo BioWorks, Inc. | 277 |
2 |
| National Health Research Institutes | 328 |
2 |
| The Trustees of Princeton University | 1210 |
2 |
| Merck Patent GmbH | 5755 |
1 |
| California Institute of Technology | 3989 |
1 |
| Life Technologies Corporation | 3343 |
1 |
| The Johns Hopkins University | 5752 |
1 |
| President and Fellows of Harvard College | 6030 |
1 |
| Novozymes A/S | 3335 |
1 |
| Vertex Pharmaceuticals Incorporated | 1621 |
1 |
| Affinity Biosciences Pty Ltd | 10 |
1 |
| Autres propriétaires | 33 |